The Chemours Company Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, The Chemours Company stock has a consensus rating of "Buy" and an average price target of $26.33. The average 1-year stock price forecast is 20.95% higher than the current stock price, while the lowest is $21 (-3.54%) and the highest is $30 (+37.80%).

Price Target: $26.33 (+20.95%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$21	$26.33	$26	$30
Change	-3.54%	+20.95%	+19.43%	+37.80%

* Price targets were last updated on May 21, 2026.

Analyst Ratings

The average analyst rating for The Chemours Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	4	4	4	4	4	4
Buy	1	1	1	1	1	1
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeffrey Zekauskas J.P. Morgan	J.P. Morgan	Hold Reiterates $17 → $22	Hold	Reiterates	$17 → $22	+1.06%	May 21, 2026
Hassan Ahmed Alembic Global	Alembic Global	Buy Reiterates $24 → $30	Buy	Reiterates	$24 → $30	+37.80%	May 13, 2026
Vincent Andrews Morgan Stanley	Morgan Stanley	Hold Maintains $17 → $21	Hold	Maintains	$17 → $21	-3.54%	May 11, 2026
Joshua Spector UBS	UBS	Buy Maintains $29 → $30	Buy	Maintains	$29 → $30	+37.80%	May 8, 2026
Arun Viswanathan RBC Capital	RBC Capital	Buy Maintains $26 → $29	Buy	Maintains	$26 → $29	+33.21%	May 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.05B

from 5.81B

4.09%

from 5.81B

Revenue Next Year

6.39B

from 6.05B

5.64%

from 6.05B

EPS This Year

1.30

from 0.95

36.61%

from 0.95

EPS Next Year

2.26

from 1.30

74.19%

from 1.30

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.35B	6.83B	6.08B	5.78B	5.81B	6.05B
Revenue Growth	27.69%	7.66%	-11.02%	-4.87%	0.45%	4.09%
Gross Profit	1.38B	1.62B	1.34B	1.14B	909.00M	1.20B
Gross Margin	21.77%	23.66%	22.08%	19.75%	15.65%	19.82%
Operating Income	691.00M	793.00M	-52.00M	415.00M	297.00M	517.19M
Net Income	608.00M	578.00M	-253.00M	69.00M	-386.00M	182.00M
EPS	-	-	-	-	0.95	1.30
EPS Growth	-	-	-	-	-21.49%	36.61%
Forward PE	7.59	9.17	9.56	8.41	8.25	16.77
Dividend / Share	1.00	1.00	1.00	1.00	0.51	0.35
Dividend Growth	-	-	-	-	-48.75%	-31.62%
Free Cash Flow	443.25M	220.75M	-135.50M	-288.00M	21.50M	194.75M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	6.3B
Avg	6.0B
Low	5.9B

Revenue Growth

Revenue Growth	2026	2027	2028
High	7.8%
Avg	4.1%
Low	1.8%

EPS Forecast

EPS	2026	2027	2028
High	1.80
Avg	1.30
Low	0.55

EPS Growth

EPS Growth	2026	2027	2028
High	89.5%
Avg	36.6%
Low	-42.1%